![MetLife, Inc. Website](https://cdn.finchat.io/185648.png)
MetLife, Inc.
NYSE-MET
Company Overview
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Name
MetLife, Inc.
CEO
Mr. Michel Abbas Khalaf
Website
www.metlife.com
Sector
Insurance
Year Founded
1999
Profile
Market Cap
$53.63B
EV
$81.09B
Shares Out
700.32M
Revenue
$68.77B
Employees
45,000
Margins
Gross
23.83%
EBITDA
7.63%
Operating
6.58%
Pre-Tax
5.41%
Net
4.23%
FCF
21.05%
Returns (5Yr Avg)
ROA
0.68%
ROTA
17.45%
ROE
9.16%
ROCE
1.03%
ROIC
0.81%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$85
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$20.79B
Net Debt
$27.17B
Debt/Equity
1.74
EBIT/Interest
4.29
Growth (CAGR)
Rev 3Yr
-0.36%
Rev 5Yr
0.9%
Rev 10Yr
-0.25%
Dil EPS 3Yr
-9.22%
Dil EPS 5Yr
-9.56%
Dil EPS 10Yr
-0.67%
Rev Fwd 2Yr
3.27%
EBITDA Fwd 2Yr
-6.48%
EPS Fwd 2Yr
16.44%
EPS LT Growth Est
14.21%
Dividends
Yield
—
Payout
56.81%
DPS
$2.11
DPS Growth 3Yr
4.21%
DPS Growth 5Yr
4.37%
DPS Growth 10Yr
6%
DPS Growth Fwd 2Yr
4.91%